| 000 | 01682 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515064634.0 | ||
| 264 | 0 | _c20070926 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.1080/10428190601175369 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFermé, Christophe | |
| 245 | 0 | 0 |
_aA weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA). _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cApr 2007 |
||
| 300 |
_a691-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBrice, Pauline | |
| 700 | 1 | _aMichallet, Anne-Sophie | |
| 700 | 1 | _aLederlin, Pierre | |
| 700 | 1 | _aDiviné, Marine | |
| 700 | 1 | _aCasasnovas, Olivier | |
| 700 | 1 | _aDevidas, Alain | |
| 700 | 1 | _aAnglaret, Bruno | |
| 700 | 1 | _aCazals-Hatem, Dominique | |
| 700 | 1 | _aMounier, Nicolas | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 48 _gno. 4 _gp. 691-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428190601175369 _zAvailable from publisher's website |
| 999 |
_c17003989 _d17003989 |
||